CeriBell, Inc. Operating Income
CeriBell, Inc. (CBLL) reported Operating Income of -$19.98 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Income Statement
us-gaap:OperatingIncomeLoss · last filed 2026-08-10
- CeriBell, Inc. operating income (loss) for the quarter ending 2026-06-30 was -$19.98M.
- CeriBell, Inc. operating income (loss) for the quarter ending 2026-03-31 was -$20.75M.
- CeriBell, Inc. operating income (loss) for the quarter ending 2025-12-31 was -$14.60M.
- CeriBell, Inc. operating income (loss) for the quarter ending 2025-09-30 was -$14.65M.
- CeriBell, Inc. operating income (loss) for fiscal 2025 was -$58.40M.
- CeriBell, Inc. operating income (loss) for fiscal 2024 was -$39.71M.
- CeriBell, Inc. operating income (loss) for fiscal 2023 was -$30.04M.
| Period end | Operating Income (Loss) 3 month | Operating Income (Loss) 6 month | Operating Income (Loss) 9 month | Operating Income (Loss) 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$19.98M 10-Q · filed 2026-08-10 | -$40.73M 10-Q · filed 2026-08-10 | -$55.32M derived: sum of 3 quarters · filed 2026-08-10 | -$69.97M derived: sum of 4 quarters · filed 2026-08-10 |
| 2026-03-31 | -$20.75M 10-Q · filed 2026-05-11 | -$35.34M derived: sum of 2 quarters · filed 2026-05-11 | -$49.99M derived: sum of 3 quarters · filed 2026-05-11 | -$64.94M derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-12-31 | -$14.60M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | -$29.24M derived: sum of 2 quarters · filed 2026-02-24 | -$44.20M derived: sum of 3 quarters · filed 2026-08-10 | -$58.40M 10-K · filed 2026-02-24 |
| 2025-09-30 | -$14.65M 10-Q · filed 2025-11-04 | -$29.60M derived: sum of 2 quarters · filed 2026-08-10 | -$43.81M 10-Q · filed 2025-11-04 | -$56.69M derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-06-30 | -$14.95M 10-Q · filed 2026-08-10 | -$29.16M 10-Q · filed 2026-08-10 | -$42.04M derived: sum of 3 quarters · filed 2026-08-10 | -$51.98M derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-03-31 | -$14.21M 10-Q · filed 2026-05-11 | -$27.09M derived: sum of 2 quarters · filed 2026-05-11 | -$37.03M derived: sum of 3 quarters · filed 2026-05-11 | -$45.46M derived: sum of 4 quarters · filed 2026-05-11 |
| 2024-12-31 | -$12.88M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | -$22.82M derived: sum of 2 quarters · filed 2026-02-24 | -$31.26M derived: sum of 3 quarters · filed 2026-02-24 | -$39.71M 10-K · filed 2026-02-24 |
| 2024-09-30 | -$9.94M 10-Q · filed 2025-11-04 | -$18.37M derived: sum of 2 quarters · filed 2025-11-04 | -$26.82M 10-Q · filed 2025-11-04 | -$35.21M derived: sum of 4 quarters · filed 2025-11-04 |
| 2024-06-30 | -$8.44M 10-Q · filed 2025-08-05 | -$16.89M 10-Q · filed 2025-08-05 | -$25.27M derived: sum of 3 quarters · filed 2025-08-05 | -$32.43M derived: sum of 4 quarters · filed 2025-08-05 |
| 2024-03-31 | -$8.45M 10-Q · filed 2025-05-08 | -$16.83M derived: sum of 2 quarters · filed 2025-05-08 | -$24.00M derived: sum of 3 quarters · filed 2025-05-08 | |
| 2023-12-31 | -$8.38M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-25 | -$15.54M derived: sum of 2 quarters · filed 2025-02-25 | -$30.04M 10-K · filed 2025-02-25 | |
| 2023-09-30 | -$7.16M 10-Q · filed 2024-11-12 | -$21.66M 10-Q · filed 2024-11-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CONMED Corp (CNMD) | United States | $1.353B | 26.72 |
| CapsoVision, Inc (CV) | United States | $0.310B | -12.68 |
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| EDAP TMS SA (FOCL) | $0.171B | ||
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |
| Vivani Medical, Inc. (VANI) | United States | $0.111B | |
| electroCore, Inc. (ECOR) | United States | $0.102B | |
| Neuraxis, INC (NRXS) | United States | $0.097B | |
| Nexalin Technology, Inc. (NXL) | United States | $0.094B | |
| Streamex Corp. (STEX) | United States | $0.089B | -0.19 |